Eikon Therapeutics Inc. (EIKN) Live Share Price, Invest From India

Eikon Therapeutics Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$9.84
Day's Price Range
$11.63
$11.45
14.06%
Downside
1.57%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$11.45
100.00%
Downside
-100.00%
Upside

Eikon Therapeutics Inc. share price movements today

Previous Close: $9.85
Open: $9.84
Volume: 631.5K
Day's Low - High: $9.84 - $11.63

Eikon Therapeutics Inc. Historical Returns

1 Month Return: -0.51 %
3 Month Return: -6.46 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Eikon Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Eikon Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$558.2M

EPS (TTM)

-6.3488

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-125.02%

Eikon Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eikon Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eikon Therapeutics Inc.	NA	$558.2M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Indian Investors' Interest in Eikon Therapeutics Inc. Stock

Search interest for Eikon Therapeutics Inc. Stock has increased by 92% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:92% versus previous 30 day period

Eikon Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Mar 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-
Gross Profit	-	-	-5	-5
Operating Income	-67	-71	-83	-87
EBITDA	-	-	-74	-77
Interest Expense	0	-	0	-
Depreciation	6	6	5	5
Income Before Tax	-64	-68	-79	-82
Income Tax Expense	-	-	-	-
Net Income	-64	-68	-79	-82
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Eikon Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-24
Operating Income	-265	-260	-338
EBITDA	-	-	-299
Interest Expense	0	0	0
Depreciation	17	25	24
Income Before Tax	-241	-243	-324
Income Tax Expense	-	-	-
Net Income	-241	-243	-324
Net Profit Margin	0.00%	0.00%	0.00%

Eikon Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2025	Dec 2025	Mar 2026
Net Income	-68	-79	-82
Operating Cash Flow	-54	-41	-89
Investing Cash Flow	-	40	-203
Financing Cash Flow	350	1	349
Change in Cash	81	0	56

Eikon Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-243	-324
Operating Cash Flow	-134	-188
Investing Cash Flow	-	-181
Financing Cash Flow	0	352
Change in Cash	16	-17

Global Institutional Holdings in Eikon Therapeutics Inc.

Funds	Holdings
EcoR1 Capital, LLC	1.35%
Franklin Resources Inc	0.65%
Merck & Co Inc	3.08%
Ensign Peak Advisors Inc	0.37%
T. Rowe Price Investment Management,Inc.	2.26%

See all

Insights on Eikon Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, EIKN stock has moved up by 19.1%

About Eikon Therapeutics Inc.

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

Organisation	Eikon Therapeutics Inc.
Headquarters	230 Harriet Tubman Way, Millbrae, CA, United States, 94030
Industry	Biotechnology
CEO	Dr. Roger M. Perlmutter M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Eikon Therapeutics Inc.

Name	Title
Dr. Eric Betzig Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Alfred Lloyd Bowie Jr., Ph.D.	Treasurer & CFO
Mr. Russ Berman	Chief Technology Officer
Mr. Benjamin Bruno Thorner	Secretary, General Counsel & Chief Business Officer
Dr. Robert Tjian Ph.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Michael A. Klobuchar	Chief Operating Officer
Dr. Roy D. Baynes FACP, M.D., Ph.D.	Executive VP & Chief Medical Officer
Ms. Barbara Howes M.B.A.	Chief People Officer
Dr. Roger M. Perlmutter M.D., Ph.D.	Chairman, President & CEO

FAQs

What is Eikon Therapeutics Inc. share price today?

Eikon Therapeutics Inc. share price today is $11.45 as on June 27, 2026 at 8:45 am IST at the close of the market. Eikon Therapeutics Inc. share today touched a day high of $11.63 and a low of $9.84.

What is the 52 week high and 52 week low for Eikon Therapeutics Inc. share?

Eikon Therapeutics Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Eikon Therapeutics Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $11.45,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Eikon Therapeutics Inc.'s market capitalisation today?

Eikon Therapeutics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Eikon Therapeutics Inc. Stock (EIKN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eikon Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eikon Therapeutics Inc. Shares that will get you 0.1310 shares as per Eikon Therapeutics Inc. share price of $11.45 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Eikon Therapeutics Inc. Stock (EIKN) from India?

Indian investors can start investing in Eikon Therapeutics Inc. (EIKN) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Eikon Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:41 am IST). Based on Eikon Therapeutics Inc. share’s latest price of $11.45 as on June 27, 2026 at 8:45 am IST, you will get 0.8734 shares of Eikon Therapeutics Inc.. Learn more about fractional shares .